Literature DB >> 7508454

Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains.

H Frasa1, J Procee, R Torensma, A Verbruggen, A Algra, M Rozenberg-Arska, K Kraaijeveld, J Verhoef.   

Abstract

A total of 174 blood isolates of Escherichia coli, collected during a 5-year period at the University Hospital Utrecht, were serotyped with rabbit sera against 171 O antigens and 73 capsule (K) antigens. The four most prevalent O-antigen serotypes were O6 (n = 22), O18 (n = 19), O1 (n = 19), and O2 (n = 15). Thirty-one strains were not typeable with any of the O-antigen-typing sera. Of the 148 strains that were subjected to K-antigen serotyping, 34 strains lacked a K antigen and 41 were not typeable with the K-antigen-specific antisera used in the study. K1 was by far the most frequently found K-antigen serotype; this was followed by K2, K53, K5, K13, K7, K(A)28, and K15. Strains possessing a K1 antigen were further classified as either O-acetyl-positive (n = 12) or O-acetyl-negative (n = 21) strains. Retrospective analysis of patients infected with different E. coli isolates--nonencapsulated (n = 23), O-acetylated K1 (n = 12), and non-O-acetylated K1 (n = 21)--revealed clinical differences. More patients suffered from sepsis (94% versus 74%), and a higher rate of mortality was found in the group infected with K1 isolates (18 versus 9%) than in the group infected with nonencapsulated isolates. More patients with severe sepsis (25 versus 10%) and a higher mortality (33 versus 10%) were found in the group infected with O-acetylated K1 isolates than in the group infected with non-O-acetylated isolated. Also, the hospitalization of these patients was prolonged. Thus, O-acetylated E. coli K1 strains seem to be more virulent than non-O-acetylated K1 strains.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7508454      PMCID: PMC266371          DOI: 10.1128/jcm.31.12.3174-3178.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

Review 1.  Serology, chemistry, and genetics of O and K antigens of Escherichia coli.

Authors:  I Orskov; F Orskov; B Jann; K Jann
Journal:  Bacteriol Rev       Date:  1977-09

2.  Escherichia coli O antigen typing by means of a mechanized microtechnique.

Authors:  P A Guinée; C M Agterberg; W H Jansen
Journal:  Appl Microbiol       Date:  1972-07

3.  Survey of purported virulence factors of Escherichia coli isolated from blood, urine and stool.

Authors:  S M Opal; A Cross; P Gemski; L W Lyhte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267

Review 4.  A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.

Authors:  M S Schiffer; E Oliveira; M P Glode; G H McCracken; L M Sarff; J B Robbins
Journal:  Pediatr Res       Date:  1976-02       Impact factor: 3.756

5.  The importance of the K1 capsule in invasive infections caused by Escherichia coli.

Authors:  A S Cross; P Gemski; J C Sadoff; F Orskov; I Orskov
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

6.  Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli.

Authors:  A S Cross; K S Kim; D C Wright; J C Sadoff; P Gemski
Journal:  J Infect Dis       Date:  1986-09       Impact factor: 5.226

7.  Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.

Authors:  W R McCabe; B Kaijser; S Olling; M Uwaydah; L A Hanson
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

8.  The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. II. Clinical observations, with special reference to factors influencing prognosis.

Authors:  M P Weinstein; J R Murphy; L B Reller; K A Lichtenstein
Journal:  Rev Infect Dis       Date:  1983 Jan-Feb

9.  Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli.

Authors:  R Torensma; A van Wijk; M J Visser; A Bouter; M Rozenberg-Arska; J Verhoef
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

10.  Form variation in Escherichia coli K1: determined by O-acetylation of the capsular polysaccharide.

Authors:  F Orskov; I Orskov; A Sutton; R Schneerson; W Lin; W Egan; G E Hoff; J B Robbins
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  10 in total

1.  Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus.

Authors:  Eric L Deszo; Susan M Steenbergen; Darón I Freedberg; Eric R Vimr
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

2.  Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis.

Authors:  Ho Jun Lee; Bojana Rakić; Michel Gilbert; Warren W Wakarchuk; Stephen G Withers; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2009-06-12       Impact factor: 5.157

3.  In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies.

Authors:  W Cleare; R Cherniak; A Casadevall
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; M Poppelier; K Kraaijeveld; J Verhoef
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

5.  Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5.

Authors:  H Frasa; B Benaissa-Trouw; L Tavares; K van Kessel; W Hustinx; J Schellekens; K Kraaijeveld; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Crystal structure analysis of the polysialic acid specific O-acetyltransferase NeuO.

Authors:  Eike C Schulz; Anne K Bergfeld; Ralf Ficner; Martina Mühlenhoff
Journal:  PLoS One       Date:  2011-03-01       Impact factor: 3.240

Review 7.  Enzymatic modifications of exopolysaccharides enhance bacterial persistence.

Authors:  Gregory B Whitfield; Lindsey S Marmont; P Lynne Howell
Journal:  Front Microbiol       Date:  2015-05-15       Impact factor: 5.640

8.  Identification of a capsular variant and characterization of capsular acetylation in Klebsiella pneumoniae PLA-associated type K57.

Authors:  Chun-Ru Hsu; Chun-Hsing Liao; Tzu-Lung Lin; Han-Ru Yang; Feng-Ling Yang; Pei-Fang Hsieh; Shih-Hsiung Wu; Jin-Town Wang
Journal:  Sci Rep       Date:  2016-08-23       Impact factor: 4.379

Review 9.  Functions and Biosynthesis of O-Acetylated Sialic Acids.

Authors:  Chitra Mandal; Reinhard Schwartz-Albiez; Reinhard Vlasak
Journal:  Top Curr Chem       Date:  2015

10.  O-Acetylation of Capsular Polysialic Acid Enables Escherichia coli K1 Escaping from Siglec-Mediated Innate Immunity and Lysosomal Degradation of E. coli-Containing Vacuoles in Macrophage-Like Cells.

Authors:  Jinghua Yang; Wei Ma; Yuanyuan Wu; Hui Zhou; Siyu Song; Yuqi Cao; Chengxu Wang; Xiangyuan Liu; Jinwei Ren; Jinyou Duan; Zhichao Pei; Cheng Jin
Journal:  Microbiol Spectr       Date:  2021-12-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.